Mammalian fibroblasts require mitogens in order to exit from G0 (quiescence) and progress through the G1 phase of the cell cycle, although once they pass the restriction point late in G1 they can enter S phase and complete the cell cycle without mitogens [1] . Mitogenic signals are integrated through the GTPase Ras, which regulates the levels of cyclin D1 [2-5], a component of the cell cycle machinery that operates during G1 phase by activating cyclin-dependent kinase 4 (Cdk4). The accumulation of active cyclin E-Cdk2 complexes also requires Ras [6]. These two G1 cyclin-Cdk complexes act on a family of E2F-associated transcriptional repressors typified by the retinoblastoma protein (Rb) to bring about a transcriptional program that promotes passage through S phase [7-9], but can also activate DNA replication independently of Rb-E2F [10-12]. Although G1 cyclin-Cdk complexes are required for S-phase entry and can shorten G1 phase when overexpressed [13-15], it is not known whether they are sufficient for this transition. Here, we report that serum-starved (G0) diploid human fibroblasts initiate DNA synthesis upon microinjection of active G1 cyclin-Cdk complexes, but not upon microinjection of an S-phase cyclin-Cdk complex. These data indicate that G1 Cdk activation is rate-limiting for S-phase entry, and that Cdk activation is likely to be the primary function of growth factor signalling pathways that lead to DNA synthesis. 
A microinjection approach, employing activated cyclin-Cdk complexes made in insect cells, was used to examine whether active G1 cyclin-Cdk complexes are sufficient to initiate DNA replication in quiescent fibroblasts. In principle, this approach should overcome the requirement of mitogens for Cdk assembly [16] by providing the kinase in a pre-activated form. Components of the G1 complexes cyclin D1-Cdk4, cyclin E-Cdk2, and cyclin E-Cdk3, as well as of the S-phase complex cyclin A-Cdk2, were coexpressed in insect cells and purified to near homogeneity as glutathione-S-transferase (GST) fusion proteins ( Figure 1a ). The ability of the complexes to phosphorylate Rb, the best characterized physiological substrate of these kinases, was assessed in vitro. At a concentration of 6 nm, cyclin E-Cdk2 preparations were the most active in phosphorylating Rb, whereas cyclin D1-Cdk4 preparations were the least active (Figure 1b) . These kinase preparations phosphorylate Rb on a subset of its in vivo phosphorylation sites, and phosphorylation of Rb by cyclin D1-Cdk4 is sufficient to inactivate its growth suppression function in a microinjection-based cell cycle assay [17] .
Human diploid fibroblasts (WI38) were rendered quiescent by serum starvation, and kinase complexes or the indicated control proteins subsequently microinjected into the cytoplasm. Biotinylated rabbit immunoglobulin G (IgG) was included in all injected samples to facilitate identification of injected cells. After injection, cells were cultured with bromodeoxyuridine (BrdU) for either 24 or 36 hours, followed by immunofluorescence with anti-BrdU antibodies to identify cells undergoing DNA synthesis, and with Texas-red-conjugated streptavidin to identify injected cells ( Figure 2 ). Parallel uninjected cultures were supplemented with 10% serum to assess the number of cells capable of entering the cell cycle through mitogen-dependent Figure 1 (a) Analysis of cyclin-Cdk complexes. GST-cyclin A-Cdk2 (lane 1), GST-cyclin E-Cdk2 (lane 2), cyclin D1-GST-Cdk4 (lane 3), and GST-cyclin E-Cdk3 (lane 5) were purified from insect cells using glutathione-Sepharose [17] . Insect cell GST (lane 4), which binds to the affinity matrix and is found as a contaminant in kinase preparations (indicated by asterisk), was purified from uninfected cells for use as a negative control. Proteins were concentrated to ~30 µM (of the limiting subunit) in 50 mM Tris pH 7.5, 150 mM NaCl, using a Microcon-30 (Amicon). (b) The Rb kinase activity of cyclin-Cdk complexes was determined using 60 or 6 nM kinase with 9 µM p56 Rb in a 10 µl reaction containing 20 mM Tris-HCl pH 7.5, 30 mM NaCl, 10 mM MgCl 2 , and 40 µM [γ-32 P]ATP for 40 min at 37°C. After SDS-PAGE, products were visualized by autoradiography and quantitated by phosphoimager analysis. At 60 nM, Rb phosphorylation was saturated under the conditions used. Figure 3 ). When cyclin E-Cdk2 was injected, the extent of S-phase entry ranged from 17 to 32% using two independent preparations of kinase in four independent injection experiments ( Figures 2,3 and data not shown). In contrast, less than 3% of cells initiated DNA replication after 24 hours upon injection of either rabbit IgG alone or insect cell GST alone. Less than 1% of uninjected cells labeled with BrdU. Surprisingly, the extent of BrdU incorporation was substantially higher than that observed with serum-mediated cell-cycle entry, which ranged from 8 to 12% at 24 hours under these conditions. Consistent with the result of studies that used cell lines harboring inducible cyclin E [13] , injection of cyclin E alone did not induce DNA replication significantly above the levels found with GST alone (data not shown).
Upon injection of cyclin D1-Cdk4, the range of S-phase entry (14-27% using two kinase preparations) was comparable to that found with cyclin E-Cdk2 (Figures 2,3 ). Previous studies have shown that the individual effects of cyclin D1 and cyclin E overexpression on the rate of S-phase entry from quiescence are additive [13] . Similarly, we found that injection of a mixture of cyclin E-Cdk2 and cyclin D1-Cdk4 resulted in an even greater proportion (31-4 7%) of cells entering S phase than injection of either kinase alone, comparable to the sum of the effects of each individual kinase in each experiment (Figure 3a ,b). This additive effect is most likely to reflect simply higher kinase levels: we did not find evidence for synergy under any conditions tested. We cannot, however, rule out the possibility that quiescent cells display two regulatory states, one competent for cyclin E-Cdk2-mediated S-phase entry, and the other competent for cyclin D1-Cdk4-mediated entry. In this case, an additive effect would reflect cell-cycle entry by both populations. As expected, the fraction of injected cells undergoing DNA synthesis upon cyclin-Cdk injection was more at the 36 hour time point (30-49% BrdUpositive cells) than at the 24 hour time point (Figure 3a ).
In our initial experiments, we used kinase concentrations which, when introduced into the cells, would exceed the normal levels in cycling fibroblasts. The rationale for this was to overcome inhibitory barriers set up in quiescent cells, such as might be produced by the presence of excess Cdk inhibitors. Cycling WI38 cells contain approximately 0.2 × 10 6 molecules of Cdk2 [18] . By injecting 10 µM kinase complexes, we estimate that, on average, 0.6-1.2 × 10 6 molecules of kinase are delivered to each cell. To examine the effects of more physiological levels of Cdk-cyclin complexes on entry into S phase from quiescence, a titration experiment was performed ( Figure 3d ). Injection of 2.5 µM cyclin D1-Cdk4 or cyclin E-Cdk2 -a concentration similar to the endogenous levels of Cdk2 -also led to S-phase entry in 5-8% of cells. A comparable fraction of cells underwent DNA synthesis in response to serum in this experiment (8%; Figure 3d ). Thus, the levels of active Cdks required to induce DNA replication in quiescent fibroblasts are comparable to those found in cycling cells. At the highest level of injected Cdk complexes, we routinely found additive effects when cyclin D1-Cdk4 and cyclin E-Cdk2 were coinjected (Figure 3a,b,d ), but at lower levels of injected kinase (Figure 3d ) a strict additive effect was not observed. Although the reason for this is not clear, it may reflect a requirement for a certain threshold level of kinase for S-phase entry. In this regard, a significant fraction of the injected kinase (20-50%) fails to translocate to the nucleus 24 hours after injection (data not shown), and the kinetics and efficiency of nuclear uptake may not be linear at lower concentrations.
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Figure 2
Visualization of DNA replication in cyclin-Cdkinjected quiescent fibroblasts by fluorescence microscopy. Mid-passage (14-20 doublings) normal diploid human fibroblast (WI38) cells were seeded at 50-70% confluence in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal calf serum (FCS). At 95% confluence, cells were washed with PBS and incubated for 4 days in DMEM plus 0.1% FCS. Cytoplasmic microinjections of the indicated proteins were performed using an Eppendorf micromanipulator and microinjector with femtotip capillary micropipets as described [17] . After injection, cells were labeled with 10 µM BrdU in media containing 0.1% FCS for 24 or 36 h. To measure serumdependent DNA synthesis, control cells were stimulated with 10% serum in the presence of BrdU. Cells were co-immunostained with Texas-red-streptavidin (red) to visualize the injection marker (biotinylated rabbit IgG), and anti-BrdU followed by flourescein-conjugated anti-mouse IgG to visualize BrdU incorporation (green). Cells were also stained with DAPI (blue) to visualize nuclei. For the panels of uninjected and cyclin A-Cdk2-injected cells, fields were selected to show a rare BrdUlabeled cell found in < 3% of injected cells.
Previous studies have suggested that Cdk3 and Cdk2 play distinct roles in S-phase entry [19, 20] . For example, a dominant-negative form of Cdk3 blocks cell-cycle progression in G1 and this arrest cannot be overcome by expression of Cdk2, and vice versa [19] . Although endogenous cyclin activators of Cdk3 have not been identified, cyclin E is a candidate: Cdk3 is thought to function at a time when cyclin E levels are maximal [19] , and cyclin E can activate Cdk3 in insect cells [18] . We investigated whether induction of cell-cycle entry by cyclin E was specific to Cdk2, and found that cyclin E-Cdk3 could also induce replication in quiescent cells. Injection of cyclin E-Cdk3 led to S-phase entry in approximately 33% of injected cells after 24 hours, compared with 6% BrdU-positive cells in the presence of serum, and 1% in IgGinjected cells (Figure 3c ). The extent of S-phase entry observed with cyclin E-Cdk3 was comparable to that observed with cyclin D1-Cdk4 injection (28%) in the same experiment.
There is evidence in the literature supporting the idea that cyclins can function in a redundant manner. For example, cyclin A, which has major roles in S and G2 phases, can override Rb-mediated cell-cycle arrest in G1 when overexpressed [21] . In yeast, the S-phase cyclin Clb5, as well as human cyclins A, B, C, D and E, can all complement deletions in the three CLN genes that encode G1 cyclins. Unlike cyclin E-Cdk2, however, active cyclin A-Cdk2 complexes ( Figure 1b) were unable to induce S-phase entry in quiescent fibroblasts (Figure 3c ). It was possible that cyclin A-Cdk2 could perform some, but not all, of the stimulatory functions required for S-phase entry; we therefore examined whether a stimulatory role for cyclin A-Cdk2 could be revealed by co-injection with cyclin D1-Cdk4. Whereas the effects of cyclin E-Cdk2 and cyclin D1-Cdk4 were additive, co-injection of cyclin A-Cdk2 with cyclin D1-Cdk4 did not increase the level of S-phase entry above that of cyclin D1-Cdk4 alone (Figure 3c ). We and others have previously shown that cyclin A-Cdk2 complexes bind to the CIP/KIP family of Cdk inhibitors with an affinity, as measured by kinase inhibition, similar to that of cyclin E-Cdk2 [18, 22, 23] . The finding that cyclin A-Cdk2 does not induce S-phase entry argues that Cdk inhibitor sequestration is not sufficient to activate DNA replication in this setting.
Previous studies point to a central role for Ras and related GTPases in coordinating the alterations in transcription and cellular architecture that facilitate mitogen-dependent exit from quiescence and entry into S phase. Microinjection of activated forms of Ras, Rac, and Cdc42 (but not wild-type proteins) can induce DNA synthesis in quiescent mouse fibroblasts [24, 25] , and neutralizing antibodies against Ras block DNA synthesis induced by mitogens [2, 3] . Ras can activate Rac and Rho, and is required for the induction of cyclin D1 expression during early G1 [2-5]:
induction of cyclin D1 is required for S-phase entry in Rbexpressing cells. Ras activation also leads to increased levels of cyclin E-Cdk2 activity, perhaps through the modulation of CDK inhibitors [6] . Thus, although Cdk Brief Communication 67 Here, we show that the mitogen requirement for S-phase entry in normal diploid human fibroblasts can be bypassed by the microinjection of previously activated cyclin D1-Cdk4, cyclin E-Cdk2 or cyclin E-Cdk3, but not by the S-phase kinase, cyclin A-Cdk2. Thus, pathways leading to G1 cyclin-kinase activation -either through cyclin induction, complex assembly, or Cdk inhibitor down-regulation -appear to constitute the primary ratelimiting event in the DNA synthesis signalling pathway coordinated by mitogens. Among cell-cycle control elements, the only other protein that has been shown to induce replication in quiescent rodent fibroblasts is E2F-1 [26] . When quiescent cells were microinjected with an E2F-1-expressing plasmid, 14-24% entered S phase, a level similar to that observed here with cyclin-Cdk protein injection. The ability of cyclin D1-Cdk4 to induce DNA synthesis in quiescent fibroblasts may reflect, at least in part, its ability to phosphorylate Rb, and perhaps Rb-related 'pocket' proteins. Such activity would be expected to initiate a transcriptional program compatible with S-phase progression, including cyclin E induction through Rb phosphorylation [9] . Although the expression of cyclin E in quiescent cells is not sufficient for full Cdk2 activation in the absence of serum [13] , cyclin D1-Cdk4 may generate a regulatory state that facilitates cyclin E-Cdk2 activation and a role for cyclin E in cyclin D1-mediated cell-cycle entry cannot be excluded. In contrast, the finding that cyclin E expression can activate DNA synthesis in the absence of Rb phosphorylation [10, 11] and E2F activation [10, 27] suggests that the effects observed here with cyclin E-Cdk2 may be Rb-independent. This suggestion is strengthened by the finding that phosphorylation of Rb by cyclin E-Cdk2 in vitro is not sufficient to inactivate the growth suppressive activity of Rb in a microinjection-based cell-cycle assay, whereas cyclin D1-Cdk4 can regulate Rb in this assay [17] . Regardless of the mechanisms involved, our results point to G1 cyclin-kinases as rate-limiting downstream components in the signal transduction pathway leading from the cell surface to DNA synthesis.
